Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic β cells by Bcl-2 and X-linked inhibitor of apoptosis

Human Immunology

Volumn 66, Issue 3, 2005, Pages 274-284

  Ou, Dawei ^a   Wang, Xiaojie ^a   Metzger, Daniel L ^a   James, Roger F L ^b   Pozzilli, Paolo ^c   Plesner, Annette ^a   Korneluk, Robert G ^d   Verchere, C Bruce ^a   Tingle, Aubrey J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Bcl 2; TRAIL; Type 1 diabetes; XIAP; cell apoptosis

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTO ONCOGENE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 15444380436     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.12.002     Document Type: Article

References (43)

1. A.V. Chervonsky, Y. Wang, S. Wong, I. Visintin, R.A. Flavell, C.A. Janeway, L.A. Matis The role of Fas in autoimmune diabetes Cell 89 1997 17
2. L.A. Stephens, H.E. Thomas, L. Ming, M. Grell, R. Darwiche, L. Volodin, T.W. Kay Tumor necrosis factor-activated cell death pathways in HIT-1 insulinoma cells and primary pancreatic β cells Endocrinology 140 1999 3219
3. F. Thomas, J. Wu, J.L. Contreras, C. Smyth, G. Bilbao, J. He, J. Thomas A tripartite anoikis-like mechanism causes early isolated islet apoptosis Surgery 130 2001 333
4. M. Jo, T.-H. Kin, D.-W. Seol, J.E. Esplen, K. Dorko, T.R. Billiar, S.C. Strom Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand Nat Med 6 2000 564
5. I. Pettersen, Y. Figenschau, E. Olsen, W. Bakkelund, B. Smedsröd, B. Sveinbjörnsson Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro Biochem Biophys Res Commun 296 2002 671
6. M. Matysiak, A. Jurewicz, D. Jaskolski, K. Selmaj TRAIL induces death of human oligodendrocytes isolated from adult brain Brain 125 2002 2469
7. P. Santamaria Effector lymphocytes in autoimmunity Curr Opin Immunol 13 2001 663
8. D. Ou, D.L. Metzger, X. Wang, J. Huand, P. Pozzilli, A.J. Tingle TNF-related apoptosis-inducing ligand death pathway-mediated human beta-cell destruction Diabetologia 45 2002 1678
9. S.R. Wiley, K. Schooley, P.J. Smolak, W.S. Din, C.P. Huang, J.K. Nicholl, G.R. Sutherland, T.D. Smith, C. Rauch, C.A. Smith Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673
10. R.M. Pitti, S.A. Marsters, S. Ruppert, C.J. Donahue, A. Moore, A. Ashkenazi Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J Biol Chem 271 1996 12687
11. J.P. Sheridan, S.A. Marster, R.M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C.L. Gray, K. Baker, W.I. Wood, A.D. Goddard, P. Godowski, A. Ashkenazi Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 1997 818
12. M. MacFarlane, M. Ahmad, S.M. Srinivasula, T. Femandes-Alnemri, G.M. Cohen, E.S. Alnemri Identification and molecular cloning of two novel receptor for the cytotoxic ligand TRAIL J Biol Chem 272 1997 25417
13. M.A. Degli-Esposti, P.J. Smolak, H. Walczak, J. Waugh, C.P. Huang, R.F. DuBose, R.G. Goodwin, C.A. Smith Cloning and characterization of TRAIL-R3, a novel member or the emerging TRAIL receptor family J Exp Med 186 1997 1165
14. G. Pan, J. Ni, G. Yu, Y.F. Wei, V.M. Dixit TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signaling FEBS Lett 424 1998 41
15. J.G. Emery, P. McDonnell, M.B. Burke, K.C. Deen, S. Lyn, C. Silverman, E. Dul, E.R. Appelbaum, C. Eichman, R. DiPrinzio, R.A. Dodds, I.E. James, M. Rosenberg, J.C. Lee, P.R. Young Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL J Biol Chem 273 1998 14363
16. S.-S. Cheung, D.L. Metzger, X. Wang, J. Huang, J. Tai, A.J. Tingle, D. Ou Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus Pancreas 2005 (in press).
17. W.M. Macfariane, H. Cragg, H.M. Docherty, M.L. Read, R.F.L. James, A. Aynsley-Green, K. Docherty Impaired expression of transcription factor IUF1 in a pancreatic β-cell line derived from a patient with persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis) FEBS Lett 413 1997 304
18. M.G. Baroni, M.G. Cavallo, M. Mark, L. Monetini, B. Stoehrer, P. Pozzilli Beta-cell gene expression and functional characterization of the human insulinoma cell line CM J Endocrinol 161 1999 59
19. + β cells by HLA-restricted and non-HLA-restricted pathways Hum Immunol 63 2002 256
20. C.J. Hawkins, A.G. Uren, G. Häcker, R.L. Medcalf, D. Vaux Inhibition of interleukin 1β-converting enzyme-mediated apoptosis of mammalian cells by baculovirus IAP Proc Natl Acad Sci U S A 93 1996 13796
21. L and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death Oncogene 14 1997 405
22. B. Wagenknecht, T. Glaser, U. Naumann, S. Kügler, S. Isenmann, M. Bähr, R. Korneluk, P. Liston, M. Weller Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma Cell Death Differentiation 6 1999 370
23. S.T. Smiley, M. Reers, C. Mottola-Hartshorn, M. Lin, A. Chen, T.W. Smith, G.D. Steele Jr, L.B. Chen Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1 Proc Natl Acad Sci U S A 88 1991 3671
24. A. Cossarizza, M. Baccarani-Contri, G. Kalashnikova, C. Franceschi A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-addregate forming lipophilic cation 5,5,6,6′-tetrachloro-1, 1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1) Biochem Biophys Res Commun 197 1993 40
25. J.M. Adams, S. Cory The Bcl-2 protein family arbiters of cell survival Science 281 1998 1322
26. Y. Huang, Y.C. Park, R.L. Rich, D. Segal, D.G. Myazka, H. Wu Structural basis of caspase inhibition by XIAP differential roles of the linker versus the BIR domain Cell 104 2001 781
27. S.J. Riedl, M. Renatus, R. Schwarzenbacher, Q. Zhou, C. Sun, S.W. Fesik, R.C. Liddington, G.S. Salvesen Structural basis for the inhibition of caspase-3 by XIAP Cell 104 2001 791
28. H.R. Stennicke, C.A. Ryan, G.S. Salvesen Reprieval from execution the molecular basis of caspase inhibition Trends Biochem Sci 27 2002 94
29. S. Desagher, J.-C. Martinou Mitochondria as the central control point of apoptosis Trends Cell Biol 10 2000 369
30. T.S. Griffith, D.H. Lynch TRAIL a molecule with multiple receptor and control mechanisms Curr Opin Immunol 10 1998 559
31. A. Suliman, A. Lam, R. Datta, Srivastava Intracellular mechanisms of TRAIL apoptosis through mitochondrial-dependent and -independent pathways Oncogene 20 2001 2122
32. C. Ruiz-Ruiz, A. López-Rivas Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-γ in human breast tumour cells Biochem J 365 2002 825
33. S. Fulda, E. Meyer, K.-M. Debatin Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression Oncogene 21 2002 2283
34. J. Lieberman The ABCs of granle-mediated cytotoxicity new weapons in the arsenal Nat Rev Immunol 3 2003 361
35. D. de Moissac, S. Mustapha, A.H. Greenberg, L.A. Kirshenbaum Bcl-2 activates the transcription factor NFκB through the degradation of the cytoplasmic inhibitor IκBα J Biol Chem 273 1998 23946
36. V.V. Tran, G. Chen, C.B. Newgard, H.E. Hohmeier Discrete and complementary mechanisms of protection of β cells against cytokine-induced and oxidative damage achieved by Bcl-2 overexpression and a cytokine selection strategy Diabetes 52 2003 1423
37. V.R. Sutton, D.L. Vaux, J.A. Trapani Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes J Immunol 158 1997 5783
38. J. Allison, H. Thomas, D. Beck, J.L. Brady, A.M. Lew, A. Elefanty, H. Kosaka, T.W. Kay, D.C.S. Huang, A. Strasser Transgenic overexpression of human Bcl-2 in islet β cells inhibits apoptosis but does not prevent autoimmune destruction Int Immunol 12 2000 9
39. M.G. Sanna, J.D.S. Correia, O. Ducrey, J. Lee, K. Nomoto, N. Schrantz, Q.L. Deveraux, R.J. Ulevitch IAP suppression of apoptosis involves distinct mechanisms the TAK1/JNK1 signal cascade and caspase inhibition Mol Cell Biol 22 2002 1754
40. I.S. Goping, M. Barry, P. Liston, T. Sawchuk, G. Constantinescu, K.M. Michalak, I. Shostak, D.L. Roberts, A.M. Hunter, R. Korneluk, R.C. Bleackley Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition Immunity 18 2003 355
41. Q.-S. Mi, D. Ly, S.-E. Lamhamedi-Cherradi, K.V. Salojin, L. Zhou, M. Grattan, C. Meagher, P. Zucker, Y.H. Chen, J. Nagle, D. Taub, T.L. Delovitch Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice Diabetes 52 2003 1967
42. S.-E. Lamhamedi-Cherradi, S. Zheng, R.M. Tisch, Y.H. Chen Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes Diabetes 52 2003 2274
43. D. Lawrence, Z. Shahrokh, S. Marsters, K. Achilles, D. Shih, B. Mounho, K. Hillan, K. Totpal, L. DeForge, P. Schow, J. Hooley, S. Sherwood, R. Pai, S. Leing, L. Khan, B. Gliniak, J. Bussiere, C.A. Smith, S. Strom, S. Kelley, J.A. Fox, D. Thomas, A. Ashkenazi Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions Nat Med 7 2001 383